Editorial Comment

J Urol. 2019 Jan;201(1):112. doi: 10.1097/01.ju.0000550164.56925.06.
No abstract available

Publication types

  • Comment

MeSH terms

  • 5-alpha Reductase Inhibitors*
  • Humans
  • Male
  • Oxidoreductases
  • Prostatic Neoplasms*

Substances

  • 5-alpha Reductase Inhibitors
  • Oxidoreductases